Close Menu

NEW YORK (GenomeWeb) – A PCR-based panel assay from BioMérieux affiliate BioFire Diagnostics to detect 33 common pathogens causing lower respiratory tract infections has been granted 510(k) clearance by the US Food and Drug Administration.

Additionally, a version of the panel with an extra target has obtained CE mark.

The pneumonia panel test detects 18 bacteria and eight viruses, as well as seven genetic markers of antimicrobial resistance. The Plus version of the panel detects the same 33 targets as well as the MERS-CoV virus.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Newsweek discusses the privacy issues raised by digital medicine.

A group of statisticians wants to eliminate researchers' reliance on 'statistical significance,' according to NPR.

In Nature this week: genetic analysis of Anatolian farmers, cotton genome analysis, and more.

Matt Hancock, the UK health secretary, is calling for the swift rollout of predictive genetic tests, the Guardian reports.

Mar
27
Sponsored by
Swift Biosciences

Sequencing workflows require library quantification and normalization to ensure data quality and reduce cost. 

May
08
Sponsored by
Sysmex Inostics

This webinar will present recent evidence that demonstrates how incorporating circulating tumor DNA (ctDNA) assessments into real-world patient management can influence patient care decisions, alter radiographic interpretations, and impact clinical outcomes.